Clinical Trial Update: To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis [NA]

View source ↗

Summary

A completed trial comparing carbapenem therapy alone versus carbapenem plus GM-CSF in difficult-to-treat spontaneous bacterial peritonitis to evaluate potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Carbapenem (carbapenem)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Spontaneous Bacterial Peritonitis | NA | Status: COMPLETED